Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
The Da Vinci Robotic-Assisted Surgery system, and Advanced Robotic Surgery Centre was inaugurated early this year
This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
Successfully removed peanut from the child’s left lung through bronchoscopy
Investment with representation on the Board of Directors and technical know-how
Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU
A primary investment of Rs 194.4 crore has been made
This cost-effective tool will be of immense benefit to other high burden countries as well.
Subscribe To Our Newsletter & Stay Updated
